{
  "ticker": "LTP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963309",
  "id": "02963309",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250630",
  "time": "0832",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l7gnlth7dtfh.pdf",
  "summary": "- **Regulatory Milestone Achieved**: Extractables study for SPONTAN\u00ae completed, with all compounds below ICH safety thresholds.  \n- **Next Step**: Leachables study initiated to support FDA submission, running for 24 months (data submission possible before completion).  \n- **Regulatory Pathway**: Progress remains on track for FDA 505(b)(2) submission; key Chemistry, Manufacturing, and Controls (CMC) requirement met.  \n\n*No material trading or capital markets impact identified (operational/regulatory update only).*",
  "usage": {
    "prompt_tokens": 1301,
    "completion_tokens": 111,
    "total_tokens": 1412,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-29T22:40:18.581032"
}